97 related articles for article (PubMed ID: 26569583)
1. Chromatin Modifications and Mast Cell Migration in UV-Induced Immunosuppression, an Epigenetic Piece of The Puzzle.
van Doorn R; de Gruijl F
J Invest Dermatol; 2015 Dec; 135(12):2911-2913. PubMed ID: 26569583
[TBL] [Abstract][Full Text] [Related]
2. Platelet-Activating Factor Induces Epigenetic Modifications in Human Mast Cells.
Damiani E; Puebla-Osorio N; Gorbea E; Ullrich SE
J Invest Dermatol; 2015 Dec; 135(12):3034-3040. PubMed ID: 26316070
[TBL] [Abstract][Full Text] [Related]
3. Platelet activating factor-induced expression of p21 is correlated with histone acetylation.
Damiani E; Puebla-Osorio N; Lege BM; Liu J; Neelapu SS; Ullrich SE
Sci Rep; 2017 Feb; 7():41959. PubMed ID: 28157211
[TBL] [Abstract][Full Text] [Related]
4. An essential role for platelet-activating factor in activating mast cell migration following ultraviolet irradiation.
Chacón-Salinas R; Chen L; Chávez-Blanco AD; Limón-Flores AY; Ma Y; Ullrich SE
J Leukoc Biol; 2014 Jan; 95(1):139-48. PubMed ID: 24009177
[TBL] [Abstract][Full Text] [Related]
5. Understanding the connection between platelet-activating factor, a UV-induced lipid mediator of inflammation, immune suppression and skin cancer.
Damiani E; Ullrich SE
Prog Lipid Res; 2016 Jul; 63():14-27. PubMed ID: 27073146
[TBL] [Abstract][Full Text] [Related]
6. Mast cell migration from the skin to the draining lymph nodes upon ultraviolet irradiation represents a key step in the induction of immune suppression.
Byrne SN; Limón-Flores AY; Ullrich SE
J Immunol; 2008 Apr; 180(7):4648-55. PubMed ID: 18354188
[TBL] [Abstract][Full Text] [Related]
7. Platelet-activating factor induces cell cycle arrest and disrupts the DNA damage response in mast cells.
Puebla-Osorio N; Damiani E; Bover L; Ullrich SE
Cell Death Dis; 2015 May; 6(5):e1745. PubMed ID: 25950475
[TBL] [Abstract][Full Text] [Related]
8. Tryptase-catalyzed core histone truncation: A novel epigenetic regulatory mechanism in mast cells.
Melo FR; Wallerman O; Paivandy A; Calounova G; Gustafson AM; Sabari BR; Zabucchi G; Allis CD; Pejler G
J Allergy Clin Immunol; 2017 Aug; 140(2):474-485. PubMed ID: 28108335
[TBL] [Abstract][Full Text] [Related]
9. Platelet activating factor in allergies.
Pałgan K; Bartuzi Z
Int J Immunopathol Pharmacol; 2015 Dec; 28(4):584-9. PubMed ID: 26486136
[TBL] [Abstract][Full Text] [Related]
10. Role of platelet-activating factor in leukocyte-independent plasma extravasation and mast cell activation during endotoxemia.
Walther A; Yilmaz N; Schmidt W; Bach A; Gebhard MM; Martin E; Schmidt H
J Surg Res; 2000 Oct; 93(2):265-71. PubMed ID: 11027469
[TBL] [Abstract][Full Text] [Related]
11. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE.
Mencia-Huerta JM; Lewis RA; Razin E; Austen KF
J Immunol; 1983 Dec; 131(6):2958-64. PubMed ID: 6315819
[TBL] [Abstract][Full Text] [Related]
12. [Allergy and PAF].
Fukuda T; Makino S
Tanpakushitsu Kakusan Koso; 1991 Feb; 36(3):371-8. PubMed ID: 2024020
[No Abstract] [Full Text] [Related]
13. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
Ma X; Ottino P; Bazan HE; Bazan NG
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
[TBL] [Abstract][Full Text] [Related]
14. [Chemical mediators].
Okiji T; Murota S
Tanpakushitsu Kakusan Koso; 1991 Feb; 36(2):171-84. PubMed ID: 1901997
[No Abstract] [Full Text] [Related]
15. Platelet-activating factor (PAF) and PAF antagonists in asthma.
Hosford D; Mencia-Huerta JM; Braquet P
Crit Rev Ther Drug Carrier Syst; 1990; 7(3):261-73. PubMed ID: 2073689
[TBL] [Abstract][Full Text] [Related]
16. Activation of human mast cells through the platelet-activating factor receptor.
Kajiwara N; Sasaki T; Bradding P; Cruse G; Sagara H; Ohmori K; Saito H; Ra C; Okayama Y
J Allergy Clin Immunol; 2010 May; 125(5):1137-1145.e6. PubMed ID: 20392487
[TBL] [Abstract][Full Text] [Related]
17. Effects of Rupatadine on Platelet- Activating Factor-Induced Human Mast Cell Degranulation Compared With Desloratadine and Levocetirizine (The MASPAF Study).
Munoz-Cano R; Ainsua-Enrich E; Torres-Atencio I; Martin M; Sánchez-Lopez J; Bartra J; Picado C; Mullol J; Valero A
J Investig Allergol Clin Immunol; 2017; 27(3):161-168. PubMed ID: 27758758
[TBL] [Abstract][Full Text] [Related]
18. Platelets in the immune response: Revisiting platelet-activating factor in anaphylaxis.
Gill P; Jindal NL; Jagdis A; Vadas P
J Allergy Clin Immunol; 2015 Jun; 135(6):1424-32. PubMed ID: 26051949
[TBL] [Abstract][Full Text] [Related]
19. Intestinal platelet-activating factor synthesis during Nippostrongylus brasiliensis infection in the rat.
Hogaboam CM; Befus AD; Wallace JL
J Lipid Mediat; 1991; 4(2):211-24. PubMed ID: 1659465
[TBL] [Abstract][Full Text] [Related]
20. Influence of platelet activating factor antagonists on the protamine sulphate stimulated release of histamine from peritoneal mast cells of rats in vitro.
Lohde C; Bahr T; Labes D; Grupe R
Arzneimittelforschung; 1992 Jan; 42(1):27-31. PubMed ID: 1375025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
